Philomaxcap AG: Listing document filed - All 110,334,081 shares admitted to stock exchange trading

Delivery of shares from the capital increase will take place shortly

München (pta009/12.05.2025/08:35 UTC+2)

Listing document filed

All 110,334,081 shares admitted to stock exchange trading

Delivery of shares from the capital increase will take place shortly

Munich, May 12, 2025 - Philomaxcap AG (ISIN: DE000A1A6WB2 / WKN: A1A6WB) has recently successfully completed a capital increase against contributions in kind and cash. A total of 93,326,847 new shares were subscribed and acquired at an issue price of EUR 1.00 per share. The share capital of Philomaxcap AG increased from EUR 17,007,234.00 to EUR 110,334,081.00. The entry in the commercial register was made on March 19, 2025. 93,036,431 of the new shares are attributable to the transfer of all shares in GenH2 Corp ("GenH2").

Josh McMorrow, CEO of Philomaxcap AG and Executive Chairman of GenH2, said: "GenH2 is a technology leader in liquid hydrogen infrastructure technology and equipment. With our patent-protected, technical solutions - developed by a renowned team led by NASA Hall of Fame researchers and engineers - we aim to set a new standard for liquid hydrogen systems. Conventional liquid hydrogen solutions result in losses of 20 % to 40 % due to boil-off and venting during transfer, storage and dispensing. Our technology eliminates such losses, offering significant cost benefits with the aim of positioning hydrogen as a viable alternative to diesel fuel."

As a result of the new shareholders from GenH2's existing shareholder base and the parallel cash capital increase (with subscription rights for existing shareholders), in which members of the Supervisory Board and the Management Board also participated, the free float, defined as shareholders with a stake in the total share capital of less than 3% each, has increased from 1.88% to 9.69%. The largest shareholder now is H2E Americas LLC with 38.20%.

On May 5, 2025, the listing document pursuant to Annex IX of Regulation (EU) 2017/1129 within the meaning of Art. Art. 1 para. 5 subpara. 1 letter ba) iii) Regulation (EU) 2017/1129 was deposited with the German Federal Financial Supervisory Authority ("BaFin"). It is published on the company website at www.philomaxcap.de/20.html.

The new shares will be delivered to the subscribers of the cash and non-cash capital increase after the shares have been admitted to trading on the regulated market of the Frankfurt Stock Exchange, which is expected at the beginning of next week. The new shares will be securitized in global certificates and included in the current listing of the old shares. This means that all 110,334,081 shares of the share capital with the ordinary ISIN DE000A1A6WB2 / WKN A1A6WB will soon be admitted to trading.

End of the press release

About Philomaxcap AG (www.philomaxcap.de)

Philomaxcap AG, based in Munich, is a managing holding company focused on the hydrogen industry that provides services for existing and yet-to-be-acquired investments. In 2025, the capital increase by contribution resulted in the full acquisition of GenH2 Corp., a US company specializing in liquid hydrogen technology and equipment.

About GenH2 (www.genh2.com)

GenH2, a wholly owned subsidiary of publicly traded Philomaxcap AG (FRA:HBD1), is a technology leader in liquid hydrogen infrastructure systems for advanced clean energy. GenH2's solutions enable flexible hydrogen liquefaction, as well as Zero-Loss transfer and storage systems. The company is focused on manufacturing equipment to accelerate infrastructure deployment and make hydrogen accessible for everyday use around the world. The technology team includes former NASA researchers and developers with decades of experience in researching, designing and building hydrogen solutions. Learn more about GenH2 at www.genh2.com.

Service

Investor relations contact

Maximilian Fischer

Tel.: +49 89 139 2889 0

Mail: m.fischer@philomaxcap.de

(end)

Emitter:	Philomaxcap AG Marienplatz 2 80331 München Germany
Contact Person:	Josh McMorrow
Phone:	+49 89 2155 2804
E-Mail:	info@philomaxcap.de
Website:	www.philomaxcap.de
ISIN(s):	DE000A1A6WB2 (Share)
Stock Exchange(s):	Regulated Market in Frankfurt; Free Market in Dusseldorf, Stuttgart